- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Emerging Companies and Venture Capital
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Global Human Capital and Compliance
- Investment Funds and Asset Management
- Leveraged Finance
- Mergers and Acquisitions
- Middle East and Islamic Finance and Investment
- Private Credit & Special Situations Investing
- Private Equity
- Real Estate
- Securitization
- Tax
- Technology Transactions
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Government Contracts
- Healthcare
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Construction and Engineering Disputes
- Corporate and Securities Litigation
- E-Discovery
- Intellectual Property
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- back
- Industries / Issues
- Automotive, Transportation and Mobility
- Energy
- Financial Services
- Food and Beverage
- Franchise and Hospitality
- Higher Education
- Life Sciences and Healthcare
- Technology
- #MeToo
- Buy American
- COVID-19 Vaccine Rollout
- Coronavirus
- Crisis Practice
- Environmental Agenda
- Focus on Women's Health
- Special Purpose Acquisition Companies (SPACs)
- The New Administration: Enforcement and Legislative Impact
- Careers
- News & Insights
- About
- Languages
M. Alexander Koch (Alec)
News 12 results
Recognition
May 20, 2021
Chambers USA 2021 Names 179 K&S Lawyers and 65 K&S Practice Groups as Leaders in Their Fields
Recognition
October 23, 2020
GIR Names King & Spalding to List of Top 30 Global Investigations Firms for Sixth Year
Recognition
April 24, 2020
King & Spalding Earns Top Rankings in Chambers USA 2020 Guide
In the News · Source: The Pink Sheet
December 14, 2019
Alec Koch explains if Sarepta Therapeutics needed to tell investors about its Vyondys 53 dispute resolution request
Events 3 results
Conference
September 12, 2019
Financial Services Summit
Webinar
May 31, 2017
ClinicalTrials.gov – Navigating the New Rule and the Expansion of Public Disclosure of Your Clinical Trial Data
Conference
November 15, 2016
9th Annual King & Spalding Pharmaceutical University
Insights 38 results
Newsletter
September 30, 2021
Financial Services Focus - September 2021
Newsletter
June 28, 2021
Financial Services Focus - June 2021
Newsletter
April 13, 2021
Financial Services Focus International – April 2021
Client Alert
April 1, 2021
SEC Division of Examinations – 2021 Priorities